Company to receive an additional $57 million in funding to address growing demand for domestic glass tubing and vial manufacturing capacity as part of the U.S. COVID response to accelerate vaccinations.
Company to receive an additional $57 million in funding to address growing demand for domestic glass tubing and vial manufacturing capacity as part of the U.S. COVID response to accelerate vaccinations.